Authors:
MUSACHIO JL
SCHEFFEL U
ZHAN Y
MOCHIZUKI T
FINLEY P
XIAO Y
DAVILAGARCIA M
KELLAR KJ
DANNALS RF
Citation: Jl. Musachio et al., 5-[I-123 125]IODO-3(2(S)-AZETIDINYLMETHOXY)PYRIDINE, A RADIOIODINATEDANALOG OF A-85380 FOR IN-VIVO STUDIES OF NICOTINIC ACETYLCHOLINE-RECEPTORS/, The Journal of nuclear medicine, 39(5), 1998, pp. 183-183
Authors:
XIAO YX
MEYER EL
THOMPSON JM
SURIN A
WROBLEWSKI J
KELLAR KJ
Citation: Yx. Xiao et al., RAT ALPHA-3 BETA-4 SUBTYPE OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR STABLY EXPRESSED IN A TRANSFECTED CELL-LINE - PHARMACOLOGY OF LIGAND-BINDING AND FUNCTION/, Molecular pharmacology, 54(2), 1998, pp. 322-333
Citation: M. Bertolino et al., NICOTINIC RECEPTOR MEDIATES SPONTANEOUS GABA RELEASE IN THE RAT DORSAL MOTOR NUCLEUS OF THE VAGUS, Neuroscience, 79(3), 1997, pp. 671-681
Authors:
MUSACHIO JL
SCHEFFEL U
VILLEMAGNE V
HORTI A
FINLEY P
XIAO Y
DAVILAGARCIA M
KELLAR KJ
RAVERT HT
MATHEWS WB
LONDON ED
DANNALS RF
Citation: Jl. Musachio et al., [C-11] AND [I-123 125] (+)-MEIPH AND (-)-MEIPH - ANALOGS OF EPIBATIDINE FOR IN-VIVO STUDIES OF NICOTINIC ACETYLCHOLINE-RECEPTORS/, The Journal of nuclear medicine, 38(5), 1997, pp. 235-235
Authors:
DAVILAGARCIA MI
MUSACHIO JL
PERRY DC
XIAO YX
HORTI A
LONDON ED
DANNALS RF
KELLAR KJ
Citation: Mi. Davilagarcia et al., [I-125] IPH, AN EPIBATIDINE ANALOG, BINDS WITH HIGH-AFFINITY TO NEURONAL NICOTINIC CHOLINERGIC RECEPTORS, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 445-451
Authors:
FLORES CM
DAVILAGARCIA MI
ULRICH YM
KELLAR KJ
Citation: Cm. Flores et al., DIFFERENTIAL REGULATION OF NEURONAL NICOTINIC RECEPTOR-BINDING SITES FOLLOWING CHRONIC NICOTINE ADMINISTRATION, Journal of neurochemistry, 69(5), 1997, pp. 2216-2219
Authors:
MELLON RD
HERNANDEZ MC
FLORES LR
KELLAR KJ
BAYER BM
Citation: Rd. Mellon et al., IMMUNOSUPPRESSION BY MORPHINE, NICOTINE, AND EPIBATIDINE - AUTONOMIC NERVOUS-SYSTEM INVOLVEMENT, The FASEB journal, 10(3), 1996, pp. 743-743
Authors:
XIAO Y
MEYER EL
HOUGHTLING RA
THOMPSON JM
KELLAR KJ
Citation: Y. Xiao et al., CHARACTERIZATION OF THE RAT NICOTINIC ACETYLCHOLINE-RECEPTOR SUBTYPESSTABLY EXPRESSED IN MAMMALIAN-CELLS, The FASEB journal, 10(3), 1996, pp. 3973-3973
Authors:
MUSACHIO JL
SCHEFFEL U
STATHIS M
VILLEMAGNE V
FINLEY P
HORTI A
KIMES A
LONDON ED
DAVILAGARCIA M
KELLAR KJ
DANNALS RF
Citation: Jl. Musachio et al., SYNTHESIS OF [I-125 I-123]-IPH - A RADIOLABELED ANALOG OF EPIBATIDINEFOR IN-VIVO STUDIES OF NICOTINIC ACETYLCHOLINE-RECEPTORS/, The Journal of nuclear medicine, 37(5), 1996, pp. 12-12
Authors:
HILAKIVICLARKE LA
CORDUBAN TD
TAIRA T
HITRI A
DEUTSCH S
KORPI ER
GOLDBERG R
KELLAR KJ
Citation: La. Hilakiviclarke et al., ALTERATIONS IN BRAIN MONOAMINES AND GABA(A) RECEPTORS IN TRANSGENIC MICE OVEREXPRESSING TGF-ALPHA, Pharmacology, biochemistry and behavior, 50(4), 1995, pp. 593-600
Citation: Ra. Houghtling et al., CHARACTERIZATION OF (+ -)-[H-3]EPIBATIDINE BINDING TO NICOTINIC CHOLINERGIC RECEPTORS IN RAT AND HUMAN BRAIN/, Molecular pharmacology, 48(2), 1995, pp. 280-287
Citation: Dc. Perry et Kj. Kellar, [H-3] EPIBATIDINE LABELS NICOTINIC RECEPTORS IN RAT-BRAIN - AN AUTORADIOGRAPHIC STUDY, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 1030-1034
Citation: Ed. London et al., IN-VIVO LABELING OF NICOTINIC ACETYLCHOLINE-RECEPTORS IN BRAIN WITH [H-3] EPIBATIDINE, European journal of pharmacology, 278(1), 1995, pp. 1-2
Authors:
MULRONEY SE
SKUDLAREK C
SHEMER A
LUMPKIN MD
KELLAR KJ
Citation: Se. Mulroney et al., TANDOSPIRONE STIMULATES PROLACTIN SECRETION IN THE RAT BY AN ACTION AT SEROTONIN-1A RECEPTORS, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 862-867
Citation: Ra. Travagli et al., S-ADENOSYL-L-METHIONINE MODULATES FIRING RATE OF DORSAL MOTOR NUCLEUSOF THE VAGUS NEURONS IN-VITRO, European journal of pharmacology, 264(3), 1994, pp. 385-390
Authors:
FLORES CM
ROGERS SW
PABREZA LA
WOLFE BB
KELLAR KJ
Citation: Cm. Flores et al., A SUBTYPE OF NICOTINIC CHOLINERGIC RECEPTOR IN RAT-BRAIN IS COMPOSED OF ALPHA-4-SUBUNIT AND BETA-2-SUBUNIT AND IS UP-REGULATED BY CHRONIC NICOTINE TREATMENT, Molecular pharmacology, 41(1), 1992, pp. 31-37